The combination of glucocorticoids and mTOR signaling deficiency or the mTOR signaling inhibitor rapamycin significantly alleviated the formation of acute ulcerative colitis and chronic colitis-associated cancer in later stages (Figure S8). The gene discussed is MTOR; the disease is ulcerative colitis.